LPL Financial’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Buy |
173,963
+2,250
| +1% | +$2.54K | ﹤0.01% | 4952 |
|
|
2025
Q1 | $251K | Buy |
171,713
+21,300
| +14% | +$31.1K | ﹤0.01% | 4591 |
|
|
2024
Q4 | $320K | Sell |
150,413
-1,487
| -1% | -$3.17K | ﹤0.01% | 4380 |
|
|
2024
Q3 | $425K | Buy |
151,900
+26,325
| +21% | +$73.7K | ﹤0.01% | 4063 |
|
|
2024
Q2 | $293K | Buy |
125,575
+42,455
| +51% | +$98.9K | ﹤0.01% | 4204 |
|
|
2024
Q1 | $372K | Buy |
83,120
+7,700
| +10% | +$34.4K | ﹤0.01% | 3973 |
|
|
2023
Q4 | $242K | Buy |
75,420
+37,413
| +98% | +$120K | ﹤0.01% | 4191 |
|
|
2023
Q3 | $120K | Buy |
38,007
+17,157
| +82% | +$54.4K | ﹤0.01% | 4324 |
|
|
2023
Q2 | $104K | Buy |
+20,850
| New | +$104K | ﹤0.01% | 4260 |
|